Development of macrolide resistance-associated mutations after macrolide treatment in children infected with Mycoplasma pneumoniae.
Suzuki Y, Shimotai Y, Itagaki T, Seto J, Ikeda T, Yahagi K, Mizuta K, Hongo S, Matsuzaki Y.
Suzuki Y, et al.
J Med Microbiol. 2017 Nov;66(11):1531-1538. doi: 10.1099/jmm.0.000582. Epub 2017 Oct 6.
J Med Microbiol. 2017.
PMID: 28984229
PURPOSE: To determine the timing of the emergence of macrolide-resistant mutations after macrolide treatment in individuals with Mycoplasma pneumoniae infections. METHODOLOGY: Between October 2011 and December 2013, serial pharynge …
PURPOSE: To determine the timing of the emergence of macrolide-resistant mutations after macrolide treatment in …